Is Anbio Biotechnology Stock a Good Investment?
Anbio Biotechnology Investment Advice | NNNN |
- Examine Anbio Biotechnology's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Anbio Biotechnology's leadership team and their track record. Good management can help Anbio Biotechnology navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Anbio Biotechnology's business and its evolving consumer preferences.
- Compare Anbio Biotechnology's performance and market position to its competitors. Analyze how Anbio Biotechnology is positioned in terms of product offerings, innovation, and market share.
- Check if Anbio Biotechnology pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Anbio Biotechnology's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Anbio Biotechnology Class stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Anbio Biotechnology Class is a good investment.
Sell | Buy |
Sell
Market Performance | Strong | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Anbio Biotechnology Stock
Researching Anbio Biotechnology's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if Anbio Biotechnology is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Anbio Biotechnology's research are outlined below:
| Anbio Biotechnology is way too risky over 90 days horizon | |
| Anbio Biotechnology appears to be risky and price may revert if volatility continues | |
| Latest headline from gurufocus.com: Anbio Biotechnology Shares Plummet Over 20 percent NNNN Stock News |
Anbio Biotechnology Quarterly Gross Profit |
|
Anbio Biotechnology's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.32 B.Market Cap |
|
Anbio Biotechnology's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.13 | 0.12 | |
| Return On Capital Employed | 0.12 | 0.11 | |
| Return On Assets | 0.13 | 0.12 | |
| Return On Equity | 0.14 | 0.13 |
Determining Anbio Biotechnology's profitability involves analyzing its financial statements and using various financial metrics to determine if Anbio Biotechnology is a good buy. For example, gross profit margin measures Anbio Biotechnology's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Anbio Biotechnology's profitability and make more informed investment decisions.
Basic technical analysis of Anbio Stock
As of the 23rd of July, Anbio Biotechnology shows the risk adjusted performance of 0.3253, and Mean Deviation of 5.72. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Anbio Biotechnology, as well as the relationship between them.Anbio Biotechnology's Outstanding Corporate Bonds
Anbio Biotechnology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Anbio Biotechnology Class uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Anbio bonds can be classified according to their maturity, which is the date when Anbio Biotechnology Class has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Anbio Biotechnology's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Anbio Biotechnology's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.3253 | |||
| Market Risk Adjusted Performance | 12.01 | |||
| Mean Deviation | 5.72 | |||
| Semi Deviation | 3.69 | |||
| Downside Deviation | 5.46 | |||
| Coefficient Of Variation | 285.29 | |||
| Standard Deviation | 8.92 | |||
| Variance | 79.62 | |||
| Information Ratio | 0.3305 | |||
| Jensen Alpha | 3.07 | |||
| Total Risk Alpha | 1.45 | |||
| Sortino Ratio | 0.5397 | |||
| Treynor Ratio | 12.0 | |||
| Maximum Drawdown | 46.5 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 17.08 | |||
| Downside Variance | 29.86 | |||
| Semi Variance | 13.6 | |||
| Expected Short fall | (7.18) | |||
| Skewness | 1.69 | |||
| Kurtosis | 5.84 |
| Risk Adjusted Performance | 0.3253 | |||
| Market Risk Adjusted Performance | 12.01 | |||
| Mean Deviation | 5.72 | |||
| Semi Deviation | 3.69 | |||
| Downside Deviation | 5.46 | |||
| Coefficient Of Variation | 285.29 | |||
| Standard Deviation | 8.92 | |||
| Variance | 79.62 | |||
| Information Ratio | 0.3305 | |||
| Jensen Alpha | 3.07 | |||
| Total Risk Alpha | 1.45 | |||
| Sortino Ratio | 0.5397 | |||
| Treynor Ratio | 12.0 | |||
| Maximum Drawdown | 46.5 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 17.08 | |||
| Downside Variance | 29.86 | |||
| Semi Variance | 13.6 | |||
| Expected Short fall | (7.18) | |||
| Skewness | 1.69 | |||
| Kurtosis | 5.84 |
Consider Anbio Biotechnology's intraday indicators
Anbio Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Anbio Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 46187.64 | |||
| Daily Balance Of Power | (1.02) | |||
| Rate Of Daily Change | 0.78 | |||
| Day Median Price | 43.88 | |||
| Day Typical Price | 42.58 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (9.66) | |||
| Period Momentum Indicator | (11.52) | |||
| Relative Strength Index | 87.43 |
Anbio Biotechnology Corporate Filings
| 28th of April 2025 Other Reports | ViewVerify | |
6K | 21st of February 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 19th of February 2025 Other Reports | ViewVerify | |
| 18th of February 2025 Certification of the accuracy of the financial statements and disclosures | ViewVerify |
Anbio Stock media impact
There is far too much social signal, news, headlines, and media speculation about Anbio Biotechnology that are available to investors today. This information is accessible both publicly - through Anbio Biotechnology's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Anbio-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Anbio Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Anbio Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Anbio Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Anbio Biotechnology alpha.
Anbio Biotechnology Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Anbio Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
When determining whether Anbio Biotechnology Class offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anbio Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anbio Biotechnology Class Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anbio Biotechnology Class Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Anbio Biotechnology Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anbio Biotechnology. If investors know Anbio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anbio Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.06 | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets | Return On Equity |
The market value of Anbio Biotechnology Class is measured differently than its book value, which is the value of Anbio that is recorded on the company's balance sheet. Investors also form their own opinion of Anbio Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Anbio Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anbio Biotechnology's market value can be influenced by many factors that don't directly affect Anbio Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Anbio Biotechnology's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Anbio Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anbio Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.